EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection

Mahtab Vasigh, Karen Ruth, Richard J Bleicher, Walker Lyons, Allison A Aggon, Austin D Williams

Breast Cancer Research and Treatment · 2026-06 · 217 (3)

DOI: 10.1007/s10549-026-07998-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 24.05.2026. Verfasst von Mahtab Vasigh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Node Excision. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, US Public Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The role of axillary surgery in patients with de novo metastatic breast cancer (dnMBC) undergoing primary site surgery is unclear. We evaluated patterns of axillary management and associations with overall survival (OS) in this population.

Methods

We used the National Cancer Database (2012-2020) to identify patients with dnMBC. Patients were grouped by receipt of breast surgery and axillary surgery (none, sentinel lymph node biopsy [SLNB] or axillary lymph node dissection [ALND]). Multivariable Cox proportional hazards models assessed factors associated with axillary surgery and OS.

Results

Among 39,946 eligible patients, 7,808 (19.5%) underwent surgery of the primary site, of whom 79.8% underwent axillary surgery (79.5% ALND, 20.4% SLNB). Compared with no axillary surgery, those who underwent axillary surgery had more favorable clinicodemographic characteristics (younger, fewer comorbidities, lower T stage, bone-only metastases). In patients with clinically node-negative disease, 41.6% had pathologically negative nodes, with higher rates among those with HR+/HER- disease and those who did not have systemic therapy prior to surgery. On multivariable analysis, axillary surgery was independently associated with improved OS (HR 0.70; 95% CI 0.63–0.78; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymph Node ExcisionHumansFemaleAxillaSentinel Lymph Node BiopsyAgedMiddle AgedLymphatic MetastasisAdultProportional Hazards ModelsRetrospective Studies

Stichwörter der Autor:innen

Axillary lymph node dissectionAxillary surgeryDe novo metastatic breast cancerOverall survivalSentinel lymph node biopsy

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
  • Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Division of Breast Surgery, Department of Surgery, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. austin.williams@fccc.edu.

Förderung

  • NCI NIH HHS
  • US Public Health Service

Zitieren

APA

Vasigh, M., Ruth, K., Bleicher, R. J., Lyons, W., Aggon, A. A., & Williams, A. D. (2026). Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection. Breast Cancer Research and Treatment, 217(3). https://doi.org/10.1007/s10549-026-07998-2

Vancouver

Vasigh M, Ruth K, Bleicher RJ, Lyons W, Aggon AA, Williams AD. Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection. Breast Cancer Research and Treatment. 2026;217(3). doi:10.1007/s10549-026-07998-2

BibTeX
@article{Vasigh2026,
  author = {Vasigh, Mahtab and Ruth, Karen and Bleicher, Richard J and Lyons, Walker and Aggon, Allison A and Williams, Austin D},
  title = {Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  volume = {217},
  number = {3},
  doi = {10.1007/s10549-026-07998-2}
}
Kostenlos starten →